Author | Richard M. Stone, MD | OncLive

Author | Richard M. Stone, MD

Articles

Dr. Stone on Combinations With Venetoclax in AML

May 02, 2020

Video

Richard M. Stone, MD, director of the Adult Leukemia Program, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses combinations with venetoclax (Venclexta) in acute myeloid leukemia (AML).

Dr. Stone on Monitoring Patients With AML

November 15, 2017

Video

Richard M. Stone, MD, director of the Adult Leukemia Program, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses monitoring patients with acute myeloid leukemia.

Dr. Stone on MRD in Hematologic Malignancies

October 27, 2017

Video

Richard M. Stone, MD, director of the Adult Leukemia Program, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses minimal residual disease (MRD) in hematologic malignancies.

Dr. Stone Discusses Monitoring MRD in AML

October 11, 2017

Video

Richard M. Stone, MD, director of the Adult Leukemia Program, Dana-Farber Cancer Institute, and professor of medicine, Harvard Medical School, discusses monitoring minimal residual disease in acute myeloid leukemia.

x